See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $468B | 7.8x | 18.1x | |
| $383B | 4.5x | 16.3x | |
| $236B | 4.6x | 19.2x | |
| $180B | 2.6x | 12.2x | |
| $72.1B | 3.6x | 14.6x | |
| $69.5B | 1.3x | 6.2x | |
| $68.5B | 9.3x | 40.7x | |
| $64.4B | 3.4x | 12.1x | |
| $52.8B | 3.6x | 14.2x | |
| $46.8B | 5.0x | 20.3x | |
| $43.7B | 8.6x | 37.8x | |
| $42.1B | 2.9x | 20.2x | |
| $36.6B | 2.4x | 10.6x | |
| $34.1B | 1.4x | 7.8x | |
| $25.6B | 2.2x | 14.4x | |
| $22.7B | 3.7x | 16.2x | |
| $22.3B | 2.2x | 6.5x | |
| $22.2B | 1.5x | 8.1x | |
| $22.0B | 1.9x | 11.0x | |
| $19.2B | 1.7x | 11.5x | |
| $13.2B | 7.7x | 36.8x | |
| $12.2B | 7.9x | 31.0x | |
| $12.2B | 2.1x | 14.6x | |
| $10.7B | 1.9x | 9.2x | |
| $10.5B | 7.7x | 40.8x | |
| $10.1B | 6.8x | 36.4x | |
| $9.4B | 1.5x | 8.3x | |
| $8.9B | 1.4x | 13.3x | |
| $7.8B | 1.3x | 7.4x | |
| $7.2B | 4.8x | 22.0x | |
| $6.9B | 10.0x | 31.0x | |
| $6.3B | 7.1x | 28.5x | |
| $6.2B | 1.4x | 8.2x | |
| $5.2B | 2.4x | 14.7x | |
| $5.2B | 1.8x | 7.9x | |
| $5.0B | 11.3x | 35.6x | |
| $5.0B | 9.9x | 39.6x | |
| $4.8B | 1.6x | 11.0x | |
| $4.5B | 3.9x | 24.5x | |
| $4.4B | 4.7x | 11.0x | |
| $4.0B | 1.3x | 7.7x | |
| $4.0B | 3.6x | 10.8x | |
| $3.8B | 1.1x | 6.9x | |
| $3.7B | 2.3x | 12.1x | |
| $3.5B | 1.6x | 9.8x | |
| $3.4B | 10.3x | 38.1x | |
| $3.2B | 2.2x | 11.0x | |
| $3.0B | 2.9x | 13.3x | |
| $2.7B | 1.1x | 5.2x | |
| $2.7B | 0.8x | 5.0x | |
| $2.6B | 5.9x | 21.8x | |
| $2.6B | 1.3x | 9.5x | |
| $2.6B | 3.4x | 16.5x | |
| $2.5B | 0.5x | 6.2x | |
| $2.4B | 0.9x | 7.1x | |
| $2.3B | 0.4x | 4.0x | |
| $2.3B | 2.9x | 19.0x | |
| $2.2B | 6.0x | 16.8x | |
| $2.1B | 1.0x | 6.8x | |
| $2.1B | 1.9x | 14.2x | |
| $2.1B | 1.2x | 10.2x | |
| $2.0B | 3.5x | 17.7x | |
| $1.9B | 2.7x | 13.8x | |
| $1.9B | 1.0x | 8.0x | |
| $1.8B | 0.8x | 8.7x | |
| $1.7B | 1.6x | -171.8x | |
| $1.6B | 2.5x | 11.2x | |
| $1.6B | 5.6x | 14.2x | |
| $1.6B | 1.3x | 8.9x | |
| $1.4B | 0.8x | 5.9x | |
| $1.3B | 0.6x | 5.5x | |
| $1.2B | 1.7x | 6.8x | |
| $1.1B | 8.6x | 32.5x | |
| $1.0B | 1.4x | 9.8x | |
| $961M | 3.8x | 69.9x | |
| $882M | 0.8x | 7.8x | |
| $816M | 1.9x | 8.3x | |
| $757M | 1.0x | 5.1x | |
| $752M | n/a | n/a | |
| $678M | 1.6x | 7.5x | |
| $670M | n/a | n/a | |
| $628M | n/a | n/a | |
| $616M | 0.9x | 7.0x | |
| $594M | 1.5x | 9.3x | |
| $583M | 0.4x | n/a | |
| $543M | 2.7x | -44.0x | |
| $532M | n/a | n/a | |
| $530M | 1.8x | -30.0x | |
| $505M | 0.2x | 1.4x | |
| $400M | 1.7x | n/a | |
| $391M | 1.4x | 9.7x | |
| $352M | 0.9x | 12.6x | |
| $351M | 0.9x | 10.1x | |
| $332M | n/a | n/a | |
| $330M | 1.1x | 12.1x | |
| $296M | n/a | n/a | |
| $283M | n/a | n/a | |
| $281M | 1.1x | 11.0x | |
| $235M | 1.6x | 7.1x | |
| $217M | 4.8x | 17.2x | |
| $213M | 0.4x | 11.6x | |
| $199M | 1.0x | 6.6x | |
| $190M | n/a | n/a | |
| $189M | 2.3x | 13.2x | |
| $188M | 1.0x | 4.6x | |
| $178M | 0.9x | 9.0x | |
| $138M | n/a | n/a | |
| $137M | 0.5x | 6.3x | |
| $135M | 2.3x | 8.6x | |
| $108M | 1.0x | -22.8x | |
| $93.5M | 0.4x | 7.1x | |
| $85.4M | n/a | n/a | |
| $83.4M | n/a | n/a | |
| $81.7M | 1.9x | n/a | |
| $62.7M | n/a | n/a | |
| $48.1M | 1.9x | 7.8x | |
| $40.9M | n/a | n/a | |
| $40.9M | n/a | n/a | |
| $29.9M | n/a | n/a | |
| $29.1M | n/a | n/a | |
| $20.1M | 1.1x | -12.0x | |
| $18.1M | n/a | n/a | |
| $17.1M | n/a | n/a | |
| $16.5M | n/a | n/a | |
| $13.2M | n/a | n/a | |
| $11.1M | n/a | n/a | |
| $6.1M | n/a | n/a | |
| $1.2M | n/a | n/a | |
| -$12.4M | -0.0x | -1.3x | |
| -$63.3M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty